• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动物模型在亨德拉尼帕病毒研究中的应用。

Animal Models for Henipavirus Research.

机构信息

Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA.

Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.

出版信息

Viruses. 2023 Sep 22;15(10):1980. doi: 10.3390/v15101980.

DOI:10.3390/v15101980
PMID:37896758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10610982/
Abstract

Hendra virus (HeV) and Nipah virus (NiV) are zoonotic paramyxoviruses in the genus (HNV) that emerged nearly thirty years ago. Outbreaks of HeV and NiV have led to severe respiratory disease and encephalitis in humans and animals characterized by a high mortality rate. Despite the grave threat HNVs pose to public health and global biosecurity, no approved medical countermeasures for human use currently exist against HeV or NiV. To develop candidate vaccines and therapeutics and advance the field's understanding of HNV pathogenesis, animal models of HeV and NiV have been instrumental and remain indispensable. Various species, including rodents, ferrets, and nonhuman primates (NHPs), have been employed for HNV investigations. Among these, NHPs have demonstrated the closest resemblance to human HNV disease, although other animal models replicate some key disease features. Here, we provide a comprehensive review of the currently available animal models (mice, hamsters, guinea pigs, ferrets, cats, dogs, nonhuman primates, horses, and swine) to support HNV research. We also discuss the strengths and limitations of each model for conducting pathogenesis and transmission studies on HeV and NiV and for the evaluation of medical countermeasures.

摘要

亨德拉病毒(HeV)和尼帕病毒(NiV)是近三十年前出现的副黏病毒科中的人畜共患病病毒,属于亨德拉病毒属(HNV)。HeV 和 NiV 的爆发导致了人类和动物中严重的呼吸道疾病和脑炎,其死亡率很高。尽管 HNV 对公共卫生和全球生物安全构成严重威胁,但目前尚无针对 HeV 或 NiV 的经批准的人类用途医疗对策。为了开发候选疫苗和疗法,并推进该领域对 HNV 发病机制的理解,亨德拉病毒和尼帕病毒的动物模型发挥了重要作用,并且仍然是不可或缺的。已经使用了包括啮齿动物、雪貂和非人灵长类动物(NHPs)在内的各种物种来进行 HNV 研究。在这些物种中,NHP 与人类 HNV 疾病最为相似,尽管其他动物模型也复制了一些关键的疾病特征。在这里,我们全面回顾了现有的动物模型(小鼠、仓鼠、豚鼠、雪貂、猫、狗、非人灵长类动物、马和猪),以支持 HNV 研究。我们还讨论了每种模型在进行 HeV 和 NiV 的发病机制和传播研究以及评估医疗对策方面的优缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/948111e07dbb/viruses-15-01980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/8be51aeff1ac/viruses-15-01980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/eb310540673e/viruses-15-01980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/948111e07dbb/viruses-15-01980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/8be51aeff1ac/viruses-15-01980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/eb310540673e/viruses-15-01980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5924/10610982/948111e07dbb/viruses-15-01980-g003.jpg

相似文献

1
Animal Models for Henipavirus Research.动物模型在亨德拉尼帕病毒研究中的应用。
Viruses. 2023 Sep 22;15(10):1980. doi: 10.3390/v15101980.
2
Hendra virus and Nipah virus animal vaccines.亨德拉病毒和尼帕病毒动物疫苗。
Vaccine. 2016 Jun 24;34(30):3525-34. doi: 10.1016/j.vaccine.2016.03.075. Epub 2016 May 4.
3
Animal challenge models of henipavirus infection and pathogenesis.动物挑战模型在亨德拉尼帕病毒感染和发病机制中的应用。
Curr Top Microbiol Immunol. 2012;359:153-77. doi: 10.1007/82_2012_208.
4
Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.结构导向的亨尼帕病毒受体结合蛋白突变揭示了受体使用和抗体结合表位的分子决定因素。
J Virol. 2024 Mar 19;98(3):e0183823. doi: 10.1128/jvi.01838-23. Epub 2024 Mar 1.
5
Infection and transmission of henipavirus in animals.亨德拉尼帕病毒在动物中的感染与传播。
Comp Immunol Microbiol Infect Dis. 2024 Jun;109:102183. doi: 10.1016/j.cimid.2024.102183. Epub 2024 Apr 17.
6
Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.基于 Fc 的重组亨尼帕病毒疫苗可在小鼠中诱导广泛的中和抗体反应。
Viruses. 2020 Apr 23;12(4):480. doi: 10.3390/v12040480.
7
Recent developments in experimental animal models of Henipavirus infection.亨尼帕病毒感染实验动物模型的最新进展。
Pathog Dis. 2014 Jul;71(2):199-206. doi: 10.1111/2049-632X.12149. Epub 2014 Feb 26.
8
Prefusion stabilization of the Hendra and Langya virus F proteins.亨德拉病毒和琅琊病毒F蛋白的融合前稳定化
J Virol. 2024 Feb 20;98(2):e0137223. doi: 10.1128/jvi.01372-23. Epub 2024 Jan 12.
9
Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models.亨尼帕病毒免疫逃逸和发病机制:从自然感染和动物模型中得到的启示。
Viruses. 2022 Apr 29;14(5):936. doi: 10.3390/v14050936.
10
Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.无头亨尼帕病毒受体结合糖蛋白揭示了头部/茎干界面的融合调节作用以及头部结构域在后受体结合过程中的贡献。
J Virol. 2021 Sep 27;95(20):e0066621. doi: 10.1128/JVI.00666-21. Epub 2021 Jul 21.

引用本文的文献

1
Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice.基于尼帕病毒糖蛋白G表位的肽疫苗在小鼠中的设计及初步免疫原性评估
Vaccines (Basel). 2025 Apr 18;13(4):428. doi: 10.3390/vaccines13040428.
2
Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein.强效交叉中和抗体揭示了亨尼帕病毒融合糖蛋白的脆弱性。
Adv Sci (Weinh). 2025 Jul;12(27):e2501996. doi: 10.1002/advs.202501996. Epub 2025 Apr 29.
3
Pathology and host-pathogen interactions in a golden Syrian hamster model of Nipah virus infection.

本文引用的文献

1
Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge.在仓鼠中建立尼帕病毒病模型,包括鼻内和腹腔内攻毒途径的比较。
Pathogens. 2023 Jul 26;12(8):976. doi: 10.3390/pathogens12080976.
2
Henipavirus-induced neuropathogenesis in mice.亨尼帕病毒在小鼠中引发的神经病变机制
Virology. 2023 Oct;587:109856. doi: 10.1016/j.virol.2023.109856. Epub 2023 Jul 29.
3
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.
尼帕病毒感染的金黄叙利亚仓鼠模型中的病理学及宿主-病原体相互作用
Front Vet Sci. 2025 Mar 7;12:1518358. doi: 10.3389/fvets.2025.1518358. eCollection 2025.
4
Cross-protectivity of henipavirus soluble glycoprotein in an model of Nipah virus disease.亨尼帕病毒可溶性糖蛋白在尼帕病毒病模型中的交叉保护性
Front Immunol. 2025 Feb 26;16:1517244. doi: 10.3389/fimmu.2025.1517244. eCollection 2025.
5
Optimization of a panel of behavioral tests for use in containment using a golden Syrian hamster model.使用金黄叙利亚仓鼠模型优化用于隔离的一组行为测试。
J Virol Methods. 2025 Jun;335:115132. doi: 10.1016/j.jviromet.2025.115132. Epub 2025 Mar 3.
6
Cedar virus biology and its applications as a surrogate for highly pathogenic henipaviruses.雪松病毒生物学及其作为高致病性亨尼帕病毒替代物的应用。
Cell Insight. 2024 Jul 2;3(4):100181. doi: 10.1016/j.cellin.2024.100181. eCollection 2024 Aug.
7
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics.亨尼帕病毒:流行病学、生态学、疾病以及疫苗和治疗方法的发展
Clin Microbiol Rev. 2025 Mar 13;38(1):e0012823. doi: 10.1128/cmr.00128-23. Epub 2024 Dec 23.
8
Establishing an immune correlate of protection for Nipah virus in nonhuman primates.在非人类灵长类动物中建立尼帕病毒的保护性免疫相关指标。
NPJ Vaccines. 2024 Dec 19;9(1):244. doi: 10.1038/s41541-024-01036-2.
9
Pandemic potential of the Nipah virus and public health strategies adopted during outbreaks: Lessons from Kerala, India.尼帕病毒的大流行潜力及疫情暴发期间采取的公共卫生策略:来自印度喀拉拉邦的经验教训
PLOS Glob Public Health. 2024 Dec 19;4(12):e0003926. doi: 10.1371/journal.pgph.0003926. eCollection 2024.
10
The latest advancements in Sosuga virus (SOSV) research.索苏加病毒(SOSV)研究的最新进展。
Front Microbiol. 2024 Nov 1;15:1486792. doi: 10.3389/fmicb.2024.1486792. eCollection 2024.
单次剂量黏膜复制子-颗粒疫苗可预防尼帕病毒感染,在接种后 3 天内可有效抵抗致死性感染。
Sci Adv. 2023 Aug 4;9(31):eadh4057. doi: 10.1126/sciadv.adh4057.
4
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model.尼帕病毒感染在狨猴模型中引起器官特异性先天和炎症反应。
J Infect Dis. 2023 Aug 31;228(5):604-614. doi: 10.1093/infdis/jiad053.
5
ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys.ChAdOx1 NiV疫苗可保护非洲绿猴免受孟加拉国尼帕病毒致死性感染。
NPJ Vaccines. 2022 Dec 21;7(1):171. doi: 10.1038/s41541-022-00592-9.
6
Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.基于水疱性口炎病毒的尼帕病毒疫苗,分别表达糖蛋白 G 或融合蛋白 F,在非人灵长类动物模型中提供同源和异源保护。
EBioMedicine. 2023 Jan;87:104405. doi: 10.1016/j.ebiom.2022.104405. Epub 2022 Dec 9.
7
Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease.重组水疱性口炎病毒载体疫苗诱导针对尼帕病毒病的持久免疫力。
J Clin Invest. 2023 Feb 1;133(3):e164946. doi: 10.1172/JCI164946.
8
Pathogen spillover driven by rapid changes in bat ecology.由蝙蝠生态的快速变化驱动的病原体溢出。
Nature. 2023 Jan;613(7943):340-344. doi: 10.1038/s41586-022-05506-2. Epub 2022 Nov 16.
9
A Zoonotic Henipavirus in Febrile Patients in China.中国发热患者中的一种人畜共患亨尼帕病毒
N Engl J Med. 2022 Aug 4;387(5):470-472. doi: 10.1056/NEJMc2202705.
10
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.重组水疱性口炎病毒抗尼帕病毒疫苗具有良好的安全性:用于评估具有神经嗜性潜力的活疫苗的模型。
PLoS Pathog. 2022 Jun 27;18(6):e1010658. doi: 10.1371/journal.ppat.1010658. eCollection 2022 Jun.